Abstract
Bipolar disorder is a chronic, disabling disease that is characterized by the recurrence of thymic episodes. The role of the immune-inflammatory system in the etiopathogenesis of this affection arouses the interest of research. The aim of this work was to determine the plasma levels of the high sensitivity C reactive protein (hs-CRP) in patients with bipolar disorder in remission phase by comparing them to a control group.
A case-control cross-sectional study was conducted from 56 subjects with bipolar disorder in clinical remission, and 56 volunteers and healthy control subjects.
Mean plasma hs-CRP was significantly higher in patients with bipolar disorder than control subjects. In bipolar patients, a hs-CRP elevation was significantly associated with the disease severity item mean score.
Through this study, bipolar disorder appears to be associated with a state of chronic inflammation. This should lead to randomized controlled trials evaluating the value of anti-inflammatory drugs in the management of bipolar disorder.
Similar content being viewed by others
References
Angst J, Gamma A. Prevalence of bipolar disorders: traditional and novel approaches. Clin Approaches Bipolar Dis. 2002;1:10–4.
Bauer IE, Pascoe MC, Wollenhaupt-Aguiar B, Kapczinski F, Soares JC. Inflammatory mediators of cognitive impairment in bipolar disorder. J Psychiatr Res. 2014;56:18–27.
Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J. An inventory for measuring depression. Arch Gen Psychiatry. 1961;4:561–71.
Berk M, Kapczinski F, Andreazza AC, et al. Pathways neuroprogression in bipolar disorder: focus on inflammation, oxidative stress and neurotrophic factors. NeurosciBiobehav Rev. 2011;35:804–17.
Berk M, Williams LJ, Jacka FN, O’Neil A, Pasco JA, Moylan S, et al. So depression is an inflammatory disease, but where does the inflammation come from. BMC Med. 2013;11:200.
Brietzke E, Kauer-Sant'anna M, Teixeira AL, Kapczinski F. Abnormalities in serum chemokine levels in euthymic patients with bipolar disorder. Brain Behav Immun. 2009;23:1079–82.
Brisa S, Fernandes JS, Molendijk ML, Dodd S, Nardin P, Gonçalves CA, et al. C-reactive protein concentrations across the spectrum in bipolar disorder: a systematic review and meta-analysis. Lancet Psychiatry. 2016;3:1147–56.
Dickerson F, Stallings C, Origoni A, Vaughan C, Khushalani S, Yolken R. Elevated C-reactive protein and cognitive deficits in patients with bipolar disorder. J Affect Disord. 2013;150:456–9.
Eaton WW, Pedersen MG, Nielsen PR, Mortensen PB. Autoimmune diseases, bipolar disorder, and non-affective psychosis. Bipolar Disord. 2010;12:638–46.
Fernandes BS, Berk M, Turck CW, Steiner J, Goncalves CA. Decreased peripheral brain-derived neurotrophic factor levels are a biomarker of disease activity in major psychiatric disorders: a comparative meta-analysis. Mol Psychiatry. 2014;19:750–1.
Fries GR, Walss-Bass C, Bauer ME, Teixeira AL. Revisiting inflammation in bipolar disorder. Pharmacol Biochem Behav. 2019;177:12–9.
Gunstad J, Bausserman L, Paul RH, Tate DF, Hoth K, Poppas A, et al. C-reactive protein but not homocysteine is related to cognitive dysfunction in older adults with cardiovascular disease. Clin Neurosci. 2006;13:540–6.
Haro JM, Kamath SA, Ochoa S, Novick D, Rele K, Fargas A, et al. Global clinical scale of schizophrenia and printing: a simple instrument to measure the diversity of symptoms present in schizophrenia. Acta PsychiatrScand. 2003;107(416):16–23.
Harrison NA, Brydon L, Walker C, Gray MA, Steptoe A, Critchley HD. Inflammation causes mood changes through alterations in subgenual cingulate activity and mesolimbic connectivity. Biol Psychiatry. 2009;66:407–14.
Hayes JF, Miles J, Walters K, King M, Osborn DP. A systematic review and meta-analysis of premature mortality in bipolar affective disorder. Acta Psychiatr Scand. 2015;131:417–25.
Kilbourne AM, Cornelius JR, Han X, Pincus HA, Shad M, Salloum I, et al. Burden of general medical conditions with bipolar disorder. Bipolar Disord. 2004;6(5):368–73.
Louveau A, Smirnov I, Keyes TJ, Eccles JD, Rouhani SJ, Peske JD, et al. Structural and functional features of central nervous system lymphatic vessels. Nature. 2015;523:337–41.
Modabbernia A, Taslimi S, Brietzke E, Ashrafi M. Cytokine alterations in bipolar disorder: a meta-analysis of 30 studies. Biol Psychiatry. 2013;74:15–25.
Ramlawi B, Rudolph JL, Mieno S, Khabbaz K, Sodha NR, Boodhwani M, et al. Serologic markers of brain injury and cognitive function after cardiopulmonary bypass. Ann Surg. 2006;244:593–601.
Rosenblat JD, Cha DS, Mansur RB, McIntyre RS. Inflamed moods: a review of the interactions between inflammation and mood disorders. Biol Psychiatry. 2014;53:23–34.
Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, et al. The Mini International Neuropsychiatric Interview (MINI): The Development and Validation of a Structured Diagnostic Psychiatric Interview for DSM-IV and ICD-10. J Clin Psychiatry. 1998;59(20):22–33.
Stertz L, Magalhaes PV, Kapczinski F. Is bipolar disorder an inflammatory condition? The relevance of microglial activation. CurrOpin Psychiatry. 2013;26:19–26.
Young AH. The effects of HPA axis on cognition and its implications for the pathophysiology of bipolar disorder. Harv Rev Psychiatry. 2014;22:331–3.
Young RC, Biggs JT, Ziegler VE, Meyer DAA. Rating scale for mania: reliability, validity and sensitivity. Br J Psychiatry. 1978;133:429–35.
Young B, Gleeson M, Cripps AW. C-reactive protein: a critical review. Pathology. 1991;23:118–24.
Acknowledgments
The author appreciates all those who participated in the study and helped to facilitate the research process.
Funding
All authors declare that they received no source of funding for this study.
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Conflict of Interest
All authors declare that they have no conflicts of interest to disclose.
Research Involving Human Participants
This study was approved by the Razi Hospital institutional Review board.
Informed Consent
All participants gave their free and informed consent in writing to participate in the study.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Hamdi, G., Ammar, H.B., Khelifa, E. et al. High-Sensitive c-Reactive Protein Levels in Euthymic Bipolar Patients: Case-Control Study. Psychiatr Q 92, 803–811 (2021). https://doi.org/10.1007/s11126-020-09854-y
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11126-020-09854-y